Evidence map›Paper›PMID 35980294›Full record

ArticleDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus2022

Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society.

Anju Murayama, Sae Kamamoto, Haruki Shigeta, Hiroaki Saito, Erika Yamashita, Tetsuya Tanimoto, Ozaki Akihiko

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Anju MurayamaMedical Governance Research Institute, Minato-ku, Japan.ORCID 0000-0002-4279-4748
Sae KamamotoMedical Governance Research Institute, Minato-ku, Japan.
Haruki ShigetaMedical Governance Research Institute, Minato-ku, Japan.
Hiroaki SaitoMedical Governance Research Institute, Minato-ku, Japan.
Erika YamashitaMedical Governance Research Institute, Minato-ku, Japan.
Tetsuya TanimotoMedical Governance Research Institute, Minato-ku, Japan.
Ozaki AkihikoMedical Governance Research Institute, Minato-ku, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Conflict of InterestEsophageal NeoplasmsHumansJapanPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID35980294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.